HK1125386A1 - Human semen enhancer of viral infection peptides (sevi) and their use - Google Patents

Human semen enhancer of viral infection peptides (sevi) and their use

Info

Publication number
HK1125386A1
HK1125386A1 HK09103156.5A HK09103156A HK1125386A1 HK 1125386 A1 HK1125386 A1 HK 1125386A1 HK 09103156 A HK09103156 A HK 09103156A HK 1125386 A1 HK1125386 A1 HK 1125386A1
Authority
HK
Hong Kong
Prior art keywords
peptides
sevi
viral infection
human semen
enhancer
Prior art date
Application number
HK09103156.5A
Other languages
English (en)
Inventor
Ludger Staendker
Wolf-Georg Forssmann
Knut Adermann
Jan Muench
Frank Kirchhoff
Elke Ruecker
Original Assignee
Viro Pharmaceuticals Gmbh & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viro Pharmaceuticals Gmbh & Co filed Critical Viro Pharmaceuticals Gmbh & Co
Publication of HK1125386A1 publication Critical patent/HK1125386A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pregnancy & Childbirth (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK09103156.5A 2006-01-25 2009-04-02 Human semen enhancer of viral infection peptides (sevi) and their use HK1125386A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06100818 2006-01-25
PCT/EP2007/050727 WO2007085630A1 (en) 2006-01-25 2007-01-25 Human semen enhancer of viral infection peptides (sevi) and their use

Publications (1)

Publication Number Publication Date
HK1125386A1 true HK1125386A1 (en) 2009-08-07

Family

ID=36423519

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09103156.5A HK1125386A1 (en) 2006-01-25 2009-04-02 Human semen enhancer of viral infection peptides (sevi) and their use

Country Status (8)

Country Link
US (1) US8299031B2 (xx)
EP (1) EP1981906B1 (xx)
JP (1) JP2009524420A (xx)
AT (1) ATE461216T1 (xx)
DE (1) DE602007005354D1 (xx)
DK (1) DK1981906T3 (xx)
HK (1) HK1125386A1 (xx)
WO (1) WO2007085630A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2071024A1 (en) * 2007-12-14 2009-06-17 Pharis Biotec GmbH Peptides of human prostatic acid phosphatase enhancing viral infectivity
JP6175055B2 (ja) * 2011-06-30 2017-08-02 ジェネトン ウイルス感染増強特性を有するペプチドおよびその使用
CN108977412A (zh) 2012-01-26 2018-12-11 生命科技公司 用于提高病毒感染性的方法
WO2022004707A1 (ja) * 2020-06-30 2022-01-06 国立大学法人大阪大学 ＳＡＲＳ－ＣｏＶ－２吸着担体およびそれを含むカラム
CN115708506B (zh) * 2022-11-14 2024-01-26 海南大学 一种马氏珠母贝精子低温保存方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6080409A (en) * 1995-12-28 2000-06-27 Dendreon Corporation Immunostimulatory method
EP1911461B1 (en) * 2000-10-19 2011-12-07 Epimmune Inc. HLA class I and II binding peptides and their uses
GB0406054D0 (en) * 2004-03-17 2004-04-21 Univ Nottingham Trent Prostatic acid phosphatase antigens

Also Published As

Publication number Publication date
EP1981906A1 (en) 2008-10-22
ATE461216T1 (de) 2010-04-15
EP1981906B1 (en) 2010-03-17
DE602007005354D1 (de) 2010-04-29
US20090191206A1 (en) 2009-07-30
WO2007085630A1 (en) 2007-08-02
JP2009524420A (ja) 2009-07-02
US8299031B2 (en) 2012-10-30
DK1981906T3 (da) 2011-01-10

Similar Documents

Publication Publication Date Title
EA201200277A1 (ru) Антитела против респираторного синцитиального вируса (pcb) и способы их применения
BRPI0513959A (pt) anticorpos dirigidos contra o peptìdeo beta-amilóide, suas composições farmacêuticas, kit e métodos de fabricação dos mesmos
PH12016500859B1 (en) Anti-human respiratory syncytial virus (rsv) antibodies and methods of use
NO20076021L (no) Antistoffer rettet mot amyloid-betapeptid og metoder som anvender de samme
HK1125386A1 (en) Human semen enhancer of viral infection peptides (sevi) and their use
MA28153A1 (fr) Acides nucléiques se liant spécifiquement à la ghréline biologiquement active
NZ513498A (en) Monoclonal antibodies, antigens and diagnosis and therapy of malignant diseases
JP2009537143A5 (xx)
EP2987807A3 (en) Antibodies recognising phospho-tau
EA201300125A1 (ru) Комбинированная фармацевтическая композиция и способ лечения заболеваний или состояний желудочно-кишечного тракта функциональной этиологии
EP2292645A3 (en) Small Streptococcus pyogenes antigens and their use
ATE543804T1 (de) Neue verbindungen
EA201600476A1 (ru) Вариант вируса ppcc, клон кднк вируса ppcc европейского типа и их применение
TW200718783A (en) Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
MX2020006328A (es) Composición inmunogénica.
EP2269626A3 (en) Protective proteins of S. agalactiae, combinations thereof and methods of using the same
MX2009005026A (es) Anticuerpos anti-tsg101 y sus usos para tratamiento de infecciones virales.
WO2008137733A3 (en) Micellar structures, methods of making micellar structures, methods of imaging, and methods of delivering agents
WO2006120019A3 (en) Mcm9, a member of the mcm2-8 family and its use in pharmaceutical compositions
CA2519012C (en) A method for the in vitro assessment of the progression status of an infection by an hiv virus in an individual
MX2012004448A (es) Clones infecciosos de torque teno virus.
WO2009130256A3 (en) Tat protein for preventing or treating aids
WO2006084694A3 (en) Use of the mcm8 gene for the preparation of a pharmaceutical composition
BRPI0716983B8 (pt) anticorpo humano isolado, ou fragmento de ligação ao antígeno do mesmo,capaz de reconhecer e se ligar a um epítopo da subunidade ha2 da proteína hemaglutinina de influenza (ha), molécula de ácido nucleico e composição farmacêutica.
WO2007030771A4 (en) TARGETED IDENTIFICATION OF IMMUNOGENIC PEPTIDES

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20150125